Dendreon is a biotechnology company focused on targeting cancer through the discovery, development, commercialization and manufacturing of novel therapeutics that may significantly improve cancer treatment options for patients. The company specializes in antigen identification, engineering and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response. DNDN is headquartered in Seattle and has manufacturing facilities in New Jersey, Georgia and California. For more information visit the company’s Web site at www.dendreon.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: